Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis [NA]

View source ↗

Summary

The study is investigating synovial tissue as a biomarker to manage pigmented villonodular synovitis and is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nantes University Hospital | Conditions: Synovitis Villonodular | NA | Status: NOT_YET_RECRUITING